If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Miriam Galbusera is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles
Thrombotic Thrombocytopenic Purpura Medicine & Life Sciences
von Willebrand Factor Medicine & Life Sciences
Hemolytic-Uremic Syndrome Medicine & Life Sciences
Kidney Medicine & Life Sciences
Complement Activation Medicine & Life Sciences
Blood Platelets Medicine & Life Sciences
Thrombosis Medicine & Life Sciences
Thrombotic Microangiopathies Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1988 2019

  • 4234 Citations
  • 27 h-Index
  • 49 Article
  • 3 Chapter

An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome

Galbusera, M., Noris, M., Gastoldi, S., Bresin, E., Mele, C., Breno, M., Cuccarolo, P., Alberti, M., Valoti, E., Piras, R., Donadelli, R., Vivarelli, M., Murer, L., Pecoraro, C., Ferrari, E., Perna, A., Benigni, A., Portalupi, V. & Remuzzi, G., Mar 6 2019, In : American Journal of Kidney Diseases.

Research output: Contribution to journalArticle

Complement Membrane Attack Complex
Hemolytic-Uremic Syndrome
Complement Activation
134 Citations (Scopus)

Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Goodship, T. H. J., Cook, H. T., Fakhouri, F., Fervenza, F. C., Frémeaux-Bacchi, V., Kavanagh, D., Nester, C. M., Noris, M., Pickering, M. C., Rodríguez de Córdoba, S., Roumenina, L. T., Sethi, S., Smith, R. J. H., Alpers, C. E., Appel, G. B., Ardissino, G., Ariceta, G., Arici, M., Bagga, A., Bajema, I. M. & 33 others, Blasco, M., Burke, L., Cairns, T. D., Carratala, M., D'Agati, V. D., Daha, M. R., De Vriese, A. S., Dragon-Durey, M. A., Fogo, A. B., Galbusera, M., Gale, D. P., Haller, H., Johnson, S., Józsi, M., Karpman, D., Lanning, L., Le Quintrec, M., Licht, C., Loirat, C., Monfort, F., Morgan, B. P., Noël, L. H., O'Shaughnessy, M. M., Rabant, M., Rondeau, E., Ruggenenti, P., Sheerin, N. S., Smith, J., Spoleti, F., Thurman, J. M., van de Kar, N. C. A. J., Vivarelli, M. & Zipfel, P. F., Mar 1 2017, In : Kidney International. 91, 3, p. 539-551 13 p.

Research output: Contribution to journalArticle

Kidney Diseases
Inborn Genetic Diseases
Complement C3
Clinical Pathology
Disease Management
12 Citations (Scopus)

Interaction between multimeric von willebrand factor and complement: A fresh look to the pathophysiology of microvascular thrombosis

Bettoni, S., Galbusera, M., Gastoldi, S., Donadelli, R., Tentori, C., Spartà, G., Bresin, E., Mele, C., Alberti, M., Tortajada, A., Yebenes, H., Remuzzi, G. & Noris, M., Aug 1 2017, In : Journal of Immunology. 199, 3, p. 1021-1040 20 p.

Research output: Contribution to journalArticle

Thrombotic Thrombocytopenic Purpura
von Willebrand Factor
Alternative Complement Pathway
Complement Membrane Attack Complex
12 Citations (Scopus)

Liver transplantation for aHUS: still needed in the eculizumab era?

Coppo, R., Bonaudo, R., Peruzzi, R. L., Amore, A., Brunati, A., Romagnoli, R., Salizzoni, M., Galbusera, M., Gotti, E., Daina, E., Noris, M. & Remuzzi, G., 2016, In : Pediatric Nephrology. 31, p. 759-768

Research output: Contribution to journalArticle

Liver Transplantation
Complement Factor H
10 Citations (Scopus)
Thrombotic Thrombocytopenic Purpura
Confidence Intervals
Odds Ratio